We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Risk of Hemolytic Uremic Syndrome After Antibiotic Treatment of Escherichia coli O157:H7 Enteritis: A Meta-analysis.
- Authors
Safdar, Nasia; Said, Adnan; Gangnon, Ronald E.; Maki, Dennis G.
- Abstract
Context: The use of antibiotics for treatment of Escherichia coli O157:H7 infection has become controversial since a recent small study found that it may increase the risk of hemolytic uremic syndrome (HUS). However, other larger studies have reported a protective effect or no association. Objective: To determine whether antibiotic therapy for E coli O157:H7 enteritis increases the risk of HUS. Data Sources: PubMed and MEDLINE computer searches were performed for studies published from January 1983 to February 2001 using the key words hemolytic uremic syndrome, risk factor, antibiotics, and Escherichia coli O157:H7. Reference lists of relevant publications were reviewed, and 12 experts in the field were contacted to identify additional reports. No language restrictions were applied to the search. Study Selection: Studies were included if they reported a series of patients with documented E coli O157:H7 enteritis, some of whom developed HUS; had clear definitions of HUS; and had adequate data delineating the relationship between antibiotic therapy and the occurrence of HUS. Nine of the 26 identified studies fulfilled these criteria. Data Extraction: Two authors (N.S. and A.S.) independently reviewed each report identified by the searches and recorded predetermined information relevant to the inclusion criteria. A pooled odds ratio was calculated using a fixed-effects model, with assessment of heterogeneity among the studies. Data Synthesis: The pooled odds ratio was 1.15 (95% confidence interval, 0.79-1.68), indicating that there does not appear to be an increased risk of HUS with antibiotic treatment of E coli O157:H7 enteritis. Incomplete reporting of data in individual studies precluded adjustment for severity of illness. Conclusion: Our meta-analysis did not show a higher risk of HUS associated with antibiotic administration. A randomized trial of adequate power, with multiple distinct strains of E coli O157:H7 represented, is needed to conclusively...
- Subjects
ESCHERICHIA coli; HEMOLYTIC-uremic syndrome; ANTIBIOTICS; DISEASE risk factors
- Publication
JAMA: Journal of the American Medical Association, 2002, Vol 288, Issue 8, p996
- ISSN
0098-7484
- Publication type
Article
- DOI
10.1001/jama.288.8.996